Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.
OBJECTIVE
C3H/HeJ (C3H) mice are extremely resistant to atherosclerosis. To identify the genetic factors involved in lesion initiation, we studied a cross between C3H and the susceptible strain C57BL/6J (B6) on a hyperlipidemic (apolipoprotein E-null) background.


RESULTS
Whereas a previous cross in mice fed a Western diet for 16 weeks revealed a very complex inheritance pattern with many significant lesion QTLs, the present cross, on a chow diet, revealed a single major locus on chromosome 9 (lod=5.0, Ath29*), and a suggestive locus on chromosome 4 (lod=2.6, Ath8). QTLs for plasma HDL, total cholesterol, and triglyceride levels were found on chromosome 1 over the ApoA2 gene. Neither of the lesion QTLs were associated with differences in plasma lipid levels or other systemic risk factors, consistent with the concept that genetic factors affecting cellular functions of the vessel wall are important determinants of atherosclerosis susceptibility. We generated a congenic strain for Ath29 and confirmed its contribution to lesion development. Toll-like receptor 4 (Tlr4), the lipopolysaccharide (LPS) receptor, is located in the Ath8 region and is known to be defective in C3H/HeJ mice. We constructed a congenic strain carrying a normal Tlr4 gene on the C3H Apoe-null background and found that the defective Tlr4 does not contribute significantly to lesion resistance during early lesion development.


CONCLUSIONS
We identified one major QTL on chromosome 9, Ath29, for early lesion development in the BXH ApoE(-/-) cross fed on a chow diet and confirmed its contribution in congenic mice. We have also determined that Tlr4 on the C3H ApoE(-/-) background does not contribute to early lesion development. *Ath29 is referred to as Ath22 in Su et al 2006.
Wang
Susanna S
SS
UCLA School of Medicine, Dept. of Human Genetics, Box 95167, University of California at Los Angeles, Los Angeles, CA 90095-1679, USA.
Shi
Weibin
W
Wang
Xuping
X
Velky
Leandra
L
Greenlee
Sarah
S
Wang
Min T
MT
Drake
Thomas A
TA
Lusis
Aldons J
AJ
D000818:Animals; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D050197:Atherosclerosis / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002874:Chromosome Mapping; D003433:Crosses, Genetic; D004041:Dietary Fats / Q000008:administration & dosage; D004195:Disease Models, Animal; D005260:Female; D020022:Genetic Predisposition to Disease; D008055:Lipids / Q000097:blood; D051379:Mice; D020297:Mice, Congenic; D008809:Mice, Inbred C3H / Q000235:genetics*; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009154:Mutation; D040641:Quantitative Trait Loci; D012307:Risk Factors; D051197:Toll-Like Receptor 4 / Q000235:genetics
D001057:Apolipoproteins E; D004041:Dietary Fats; D008055:Lipids; C493487:Tlr4 protein, mouse; D051197:Toll-Like Receptor 4